Fecal calprotectin levels in patients with fibromyalgia: A cross-sectional study.
Authors
Çınar E, Türkoğlu Aytar MB, Baklacı M, Hepgüler S, Barutçuoğlu B
Abstract
This study aimed to evaluate levels of fecal calprotectin (FC), a biomarker that helps distinguish irritable bowel syndrome from inflammatory gut disorders, in patients with fibromyalgia syndrome (FMS) and compare them to healthy controls.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
